MedTrace Logo

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

NCT01588574 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-09-08

No results posted yet for this study

Summary

The purpose of this study is to determine the Optimal dose for safety and efficacy in the treatment of cervical dystonia.

Conditions

  • Cervical Dystonia

Interventions

BIOLOGICAL

MT10109

Botulinum toxin type A

BIOLOGICAL

BOTOX(Registered trade mark)

Botulinum toxin type A

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01588574 on ClinicalTrials.gov